Just days after 10 former ministers in Greece were implicated in bribery allegations against Novartis, the country’s prime minister is calling for a special parliamentary committee to investigate the charges. Meanwhile, three ex-Novartis executives believed to be key witnesses have
read moreThe U.K. government is asking GlaxoSmithKline for more information on its China bribery scandal, AstraZeneca made two deals during U.K. Prime Minister Theresa May’s state visit to China, Samsung BioLogics’ plant expansions helped grow sales by 56% in 2017, and
read moreTesaro has been asked by NICE to submit a proposal for Zejula use on the National Health Service via the Cancer Drugs Fund for maintenance treatment of patients with relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer. More: NICE asks
read moreIt is now looking very unlikely that patients with liver cancer will get access to Bayer’s Stivarga on the NHS, after cost regulators issued final draft guidelines rejecting funding for the drug in this setting. More: Liver cancer patients barred
read moreA new long-acting reversible contraception method offering protection from unplanned pregnancy for up to five years has been launched in the UK. More: UK launch for Bayer’s five-year contraceptive Kyleena Source: News
read moreViiV Healthcare, an HIV specialist firm majority owned by GlaxoSmithKline, has announced the launch of a late-stage study investigating the effectiveness of a two-drug regimen programme in patients with HIV. More: ViiV kicks off PhIII trial of two-drug HIV regimen
read more© 1994 - 2026 B.M. Pharmaceuticals